Bromine in PDB 4wq3: Human Calpain Pef(S) with (2Z,2Z')-2,2'-Disulfanediylbis(3-(6- Bromoindol-3-Yl)Acrylic Acid) Bound
Protein crystallography data
The structure of Human Calpain Pef(S) with (2Z,2Z')-2,2'-Disulfanediylbis(3-(6- Bromoindol-3-Yl)Acrylic Acid) Bound, PDB code: 4wq3
was solved by
S.E.Adams,
E.J.Robinson,
P.J.Rizkallah,
D.J.Miller,
M.B.Hallett,
R.K.Allemann,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
39.65 /
1.79
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
49.560,
79.310,
57.020,
90.00,
91.47,
90.00
|
R / Rfree (%)
|
17.8 /
21.5
|
Other elements in 4wq3:
The structure of Human Calpain Pef(S) with (2Z,2Z')-2,2'-Disulfanediylbis(3-(6- Bromoindol-3-Yl)Acrylic Acid) Bound also contains other interesting chemical elements:
Bromine Binding Sites:
The binding sites of Bromine atom in the Human Calpain Pef(S) with (2Z,2Z')-2,2'-Disulfanediylbis(3-(6- Bromoindol-3-Yl)Acrylic Acid) Bound
(pdb code 4wq3). This binding sites where shown within
5.0 Angstroms radius around Bromine atom.
In total 8 binding sites of Bromine where determined in the
Human Calpain Pef(S) with (2Z,2Z')-2,2'-Disulfanediylbis(3-(6- Bromoindol-3-Yl)Acrylic Acid) Bound, PDB code: 4wq3:
Jump to Bromine binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
Bromine binding site 1 out
of 8 in 4wq3
Go back to
Bromine Binding Sites List in 4wq3
Bromine binding site 1 out
of 8 in the Human Calpain Pef(S) with (2Z,2Z')-2,2'-Disulfanediylbis(3-(6- Bromoindol-3-Yl)Acrylic Acid) Bound
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 1 of Human Calpain Pef(S) with (2Z,2Z')-2,2'-Disulfanediylbis(3-(6- Bromoindol-3-Yl)Acrylic Acid) Bound within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br305
b:31.2
occ:0.50
|
BR
|
A:3SU305
|
0.0
|
31.2
|
0.5
|
BR
|
A:3SU305
|
1.0
|
81.1
|
0.5
|
CAB
|
A:3SU305
|
2.0
|
37.6
|
0.5
|
CAB
|
A:3SU305
|
2.7
|
76.9
|
0.5
|
CAC
|
A:3SU305
|
2.9
|
38.7
|
0.5
|
CAG
|
A:3SU305
|
3.0
|
39.6
|
0.5
|
CAC
|
A:3SU305
|
3.4
|
74.4
|
0.5
|
O
|
A:LEU104
|
3.8
|
34.6
|
1.0
|
C
|
A:LEU104
|
3.8
|
32.3
|
1.0
|
CB
|
A:LEU104
|
3.8
|
36.9
|
1.0
|
CAG
|
A:3SU305
|
3.8
|
77.2
|
0.5
|
CE2
|
A:PHE164
|
3.9
|
25.5
|
1.0
|
CZ
|
A:PHE164
|
4.0
|
24.8
|
1.0
|
N
|
A:PHE105
|
4.0
|
30.7
|
1.0
|
CG
|
A:LEU108
|
4.2
|
44.0
|
1.0
|
CAF
|
A:3SU305
|
4.2
|
43.5
|
0.5
|
CAD
|
A:3SU305
|
4.2
|
40.2
|
0.5
|
CB
|
A:LEU108
|
4.3
|
37.4
|
1.0
|
O
|
A:HOH461
|
4.3
|
39.7
|
1.0
|
CA
|
A:LEU104
|
4.4
|
34.7
|
1.0
|
CA
|
A:PHE105
|
4.4
|
28.6
|
1.0
|
CG1
|
A:ILE123
|
4.5
|
33.0
|
1.0
|
CD1
|
A:LEU108
|
4.6
|
41.2
|
1.0
|
CG
|
A:LEU104
|
4.6
|
39.2
|
1.0
|
CAE
|
A:3SU305
|
4.7
|
42.6
|
0.5
|
CAD
|
A:3SU305
|
4.8
|
73.4
|
0.5
|
CH2
|
A:TRP168
|
4.9
|
35.4
|
1.0
|
CD1
|
A:ILE123
|
4.9
|
37.2
|
1.0
|
CZ3
|
A:TRP168
|
5.0
|
36.5
|
1.0
|
CE1
|
A:PHE101
|
5.0
|
33.7
|
1.0
|
|
Bromine binding site 2 out
of 8 in 4wq3
Go back to
Bromine Binding Sites List in 4wq3
Bromine binding site 2 out
of 8 in the Human Calpain Pef(S) with (2Z,2Z')-2,2'-Disulfanediylbis(3-(6- Bromoindol-3-Yl)Acrylic Acid) Bound
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 2 of Human Calpain Pef(S) with (2Z,2Z')-2,2'-Disulfanediylbis(3-(6- Bromoindol-3-Yl)Acrylic Acid) Bound within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br305
b:81.1
occ:0.50
|
BR
|
A:3SU305
|
0.0
|
81.1
|
0.5
|
BR
|
A:3SU305
|
1.0
|
31.2
|
0.5
|
CAB
|
A:3SU305
|
1.4
|
37.6
|
0.5
|
CAB
|
A:3SU305
|
1.9
|
76.9
|
0.5
|
CAG
|
A:3SU305
|
2.0
|
39.6
|
0.5
|
CAC
|
A:3SU305
|
2.8
|
38.7
|
0.5
|
CAG
|
A:3SU305
|
2.9
|
77.2
|
0.5
|
CAC
|
A:3SU305
|
2.9
|
74.4
|
0.5
|
CB
|
A:LEU104
|
3.3
|
36.9
|
1.0
|
CAF
|
A:3SU305
|
3.4
|
43.5
|
0.5
|
CAD
|
A:3SU305
|
3.9
|
40.2
|
0.5
|
C
|
A:LEU104
|
3.9
|
32.3
|
1.0
|
N
|
A:PHE105
|
4.0
|
30.7
|
1.0
|
CAE
|
A:3SU305
|
4.1
|
42.6
|
0.5
|
CG
|
A:LEU104
|
4.1
|
39.2
|
1.0
|
CAF
|
A:3SU305
|
4.1
|
73.0
|
0.5
|
O
|
A:LEU104
|
4.2
|
34.6
|
1.0
|
CA
|
A:LEU104
|
4.2
|
34.7
|
1.0
|
CAD
|
A:3SU305
|
4.2
|
73.4
|
0.5
|
CE2
|
A:PHE164
|
4.2
|
25.5
|
1.0
|
CE1
|
A:PHE101
|
4.3
|
33.7
|
1.0
|
CZ
|
A:PHE164
|
4.4
|
24.8
|
1.0
|
NAA
|
A:3SU305
|
4.5
|
46.2
|
0.5
|
CD1
|
A:PHE101
|
4.6
|
34.2
|
1.0
|
CZ2
|
A:TRP168
|
4.6
|
37.4
|
1.0
|
CAE
|
A:3SU305
|
4.7
|
72.4
|
0.5
|
CA
|
A:PHE105
|
4.7
|
28.6
|
1.0
|
CD2
|
A:LEU104
|
4.7
|
43.0
|
1.0
|
O
|
A:HOH461
|
4.7
|
39.7
|
1.0
|
CH2
|
A:TRP168
|
4.8
|
35.4
|
1.0
|
CE2
|
A:TRP168
|
4.8
|
35.6
|
1.0
|
O
|
A:PHE101
|
5.0
|
30.4
|
1.0
|
|
Bromine binding site 3 out
of 8 in 4wq3
Go back to
Bromine Binding Sites List in 4wq3
Bromine binding site 3 out
of 8 in the Human Calpain Pef(S) with (2Z,2Z')-2,2'-Disulfanediylbis(3-(6- Bromoindol-3-Yl)Acrylic Acid) Bound
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 3 of Human Calpain Pef(S) with (2Z,2Z')-2,2'-Disulfanediylbis(3-(6- Bromoindol-3-Yl)Acrylic Acid) Bound within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br306
b:27.0
occ:0.50
|
BR
|
A:3SU306
|
0.0
|
27.0
|
0.5
|
BR
|
A:3SU306
|
0.4
|
42.9
|
0.5
|
CAB
|
A:3SU306
|
1.9
|
28.5
|
0.5
|
CAB
|
A:3SU306
|
1.9
|
42.5
|
0.5
|
CAG
|
A:3SU306
|
2.7
|
43.8
|
0.5
|
CAC
|
A:3SU306
|
2.8
|
26.5
|
0.5
|
CAG
|
A:3SU306
|
2.9
|
28.4
|
0.5
|
CAC
|
A:3SU306
|
3.0
|
39.4
|
0.5
|
O
|
A:LEU124
|
3.7
|
26.9
|
1.0
|
CB
|
A:VAL128
|
3.8
|
29.0
|
1.0
|
CE2
|
A:PHE226
|
3.9
|
25.9
|
1.0
|
N
|
A:VAL128
|
4.0
|
28.1
|
1.0
|
CAF
|
A:3SU306
|
4.0
|
44.1
|
0.5
|
CD2
|
A:LEU124
|
4.0
|
28.5
|
1.0
|
CAD
|
A:3SU306
|
4.1
|
27.2
|
0.5
|
CAF
|
A:3SU306
|
4.1
|
28.5
|
0.5
|
CA
|
A:VAL128
|
4.1
|
29.4
|
1.0
|
CE1
|
A:PHE139
|
4.2
|
23.7
|
1.0
|
CAD
|
A:3SU306
|
4.2
|
40.9
|
0.5
|
CG1
|
A:VAL127
|
4.3
|
36.5
|
1.0
|
CA
|
A:LEU124
|
4.3
|
29.0
|
1.0
|
CB
|
A:VAL127
|
4.3
|
32.3
|
1.0
|
CG2
|
A:VAL128
|
4.4
|
31.6
|
1.0
|
C
|
A:LEU124
|
4.4
|
27.9
|
1.0
|
CB
|
A:LEU124
|
4.4
|
26.5
|
1.0
|
CZ
|
A:PHE139
|
4.4
|
23.7
|
1.0
|
CAE
|
A:3SU306
|
4.6
|
28.6
|
0.5
|
C
|
A:VAL127
|
4.6
|
31.2
|
1.0
|
CZ
|
A:PHE226
|
4.6
|
25.1
|
1.0
|
CAE
|
A:3SU306
|
4.6
|
44.6
|
0.5
|
CD2
|
A:PHE226
|
4.8
|
23.3
|
1.0
|
CG2
|
A:ILE171
|
4.8
|
26.3
|
1.0
|
CG
|
A:LEU124
|
4.8
|
26.8
|
1.0
|
CG1
|
A:VAL128
|
4.9
|
29.5
|
1.0
|
|
Bromine binding site 4 out
of 8 in 4wq3
Go back to
Bromine Binding Sites List in 4wq3
Bromine binding site 4 out
of 8 in the Human Calpain Pef(S) with (2Z,2Z')-2,2'-Disulfanediylbis(3-(6- Bromoindol-3-Yl)Acrylic Acid) Bound
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 4 of Human Calpain Pef(S) with (2Z,2Z')-2,2'-Disulfanediylbis(3-(6- Bromoindol-3-Yl)Acrylic Acid) Bound within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br306
b:42.9
occ:0.50
|
BR
|
A:3SU306
|
0.0
|
42.9
|
0.5
|
BR
|
A:3SU306
|
0.4
|
27.0
|
0.5
|
CAB
|
A:3SU306
|
1.9
|
28.5
|
0.5
|
CAB
|
A:3SU306
|
1.9
|
42.5
|
0.5
|
CAC
|
A:3SU306
|
2.7
|
26.5
|
0.5
|
CAG
|
A:3SU306
|
2.8
|
43.8
|
0.5
|
CAC
|
A:3SU306
|
2.9
|
39.4
|
0.5
|
CAG
|
A:3SU306
|
2.9
|
28.4
|
0.5
|
CE2
|
A:PHE226
|
3.7
|
25.9
|
1.0
|
CD2
|
A:LEU124
|
3.9
|
28.5
|
1.0
|
O
|
A:LEU124
|
3.9
|
26.9
|
1.0
|
CAD
|
A:3SU306
|
4.0
|
27.2
|
0.5
|
CB
|
A:VAL128
|
4.1
|
29.0
|
1.0
|
CAF
|
A:3SU306
|
4.1
|
44.1
|
0.5
|
CE1
|
A:PHE139
|
4.1
|
23.7
|
1.0
|
CAF
|
A:3SU306
|
4.1
|
28.5
|
0.5
|
CAD
|
A:3SU306
|
4.2
|
40.9
|
0.5
|
CZ
|
A:PHE139
|
4.3
|
23.7
|
1.0
|
N
|
A:VAL128
|
4.4
|
28.1
|
1.0
|
CA
|
A:LEU124
|
4.4
|
29.0
|
1.0
|
CB
|
A:LEU124
|
4.4
|
26.5
|
1.0
|
CZ
|
A:PHE226
|
4.4
|
25.1
|
1.0
|
CA
|
A:VAL128
|
4.5
|
29.4
|
1.0
|
CG2
|
A:ILE171
|
4.5
|
26.3
|
1.0
|
CG1
|
A:VAL127
|
4.5
|
36.5
|
1.0
|
CAE
|
A:3SU306
|
4.6
|
28.6
|
0.5
|
C
|
A:LEU124
|
4.6
|
27.9
|
1.0
|
CB
|
A:VAL127
|
4.6
|
32.3
|
1.0
|
CG2
|
A:VAL128
|
4.6
|
31.6
|
1.0
|
CAE
|
A:3SU306
|
4.6
|
44.6
|
0.5
|
CG
|
A:LEU124
|
4.7
|
26.8
|
1.0
|
CD2
|
A:PHE226
|
4.7
|
23.3
|
1.0
|
C
|
A:VAL127
|
4.9
|
31.2
|
1.0
|
|
Bromine binding site 5 out
of 8 in 4wq3
Go back to
Bromine Binding Sites List in 4wq3
Bromine binding site 5 out
of 8 in the Human Calpain Pef(S) with (2Z,2Z')-2,2'-Disulfanediylbis(3-(6- Bromoindol-3-Yl)Acrylic Acid) Bound
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 5 of Human Calpain Pef(S) with (2Z,2Z')-2,2'-Disulfanediylbis(3-(6- Bromoindol-3-Yl)Acrylic Acid) Bound within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Br305
b:38.8
occ:0.50
|
BR
|
B:3SU305
|
0.0
|
38.8
|
0.5
|
CAB
|
B:3SU305
|
1.8
|
35.8
|
0.5
|
CAG
|
B:3SU305
|
2.6
|
37.1
|
0.5
|
CAC
|
B:3SU305
|
2.8
|
34.4
|
0.5
|
NH1
|
B:ARG130
|
3.3
|
68.6
|
1.0
|
CD1
|
B:ILE123
|
3.9
|
26.9
|
1.0
|
CAF
|
B:3SU305
|
3.9
|
35.5
|
0.5
|
NH2
|
B:ARG130
|
4.0
|
63.3
|
1.0
|
CE
|
B:LYS126
|
4.1
|
47.6
|
1.0
|
CAD
|
B:3SU305
|
4.1
|
34.3
|
0.5
|
CZ
|
B:ARG130
|
4.1
|
65.4
|
1.0
|
CG2
|
B:VAL127
|
4.1
|
24.8
|
1.0
|
CD
|
B:LYS126
|
4.1
|
39.2
|
1.0
|
CAE
|
B:3SU305
|
4.5
|
35.0
|
0.5
|
CG
|
B:LYS126
|
4.6
|
33.9
|
1.0
|
O
|
B:HOH461
|
4.6
|
54.0
|
1.0
|
NAA
|
B:3SU305
|
4.7
|
80.8
|
0.5
|
NZ
|
B:LYS126
|
4.7
|
53.0
|
1.0
|
|
Bromine binding site 6 out
of 8 in 4wq3
Go back to
Bromine Binding Sites List in 4wq3
Bromine binding site 6 out
of 8 in the Human Calpain Pef(S) with (2Z,2Z')-2,2'-Disulfanediylbis(3-(6- Bromoindol-3-Yl)Acrylic Acid) Bound
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 6 of Human Calpain Pef(S) with (2Z,2Z')-2,2'-Disulfanediylbis(3-(6- Bromoindol-3-Yl)Acrylic Acid) Bound within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Br305
b:64.4
occ:0.50
|
BR
|
B:3SU305
|
0.0
|
64.4
|
0.5
|
CAB
|
B:3SU305
|
1.8
|
72.5
|
0.5
|
NAA
|
B:3SU305
|
2.4
|
36.7
|
0.5
|
CAC
|
B:3SU305
|
2.8
|
73.3
|
0.5
|
CAG
|
B:3SU305
|
2.8
|
75.5
|
0.5
|
CAK
|
B:3SU305
|
2.9
|
35.9
|
0.5
|
O
|
B:HOH461
|
3.0
|
54.0
|
1.0
|
NE2
|
B:HIS131
|
3.1
|
25.0
|
1.0
|
CAF
|
B:3SU305
|
3.7
|
35.5
|
0.5
|
CE1
|
B:HIS131
|
3.7
|
26.4
|
1.0
|
CAJ
|
B:3SU306
|
4.1
|
32.7
|
0.5
|
CAI
|
B:3SU306
|
4.1
|
29.5
|
0.5
|
CAD
|
B:3SU305
|
4.1
|
76.8
|
0.5
|
CAF
|
B:3SU305
|
4.1
|
78.8
|
0.5
|
CAH
|
B:3SU305
|
4.2
|
35.1
|
0.5
|
CG1
|
B:VAL127
|
4.2
|
26.3
|
1.0
|
CD2
|
B:HIS131
|
4.3
|
23.1
|
1.0
|
CAL
|
B:3SU306
|
4.3
|
35.3
|
0.5
|
SAP
|
B:3SU305
|
4.4
|
40.4
|
0.5
|
CAG
|
B:3SU305
|
4.4
|
37.1
|
0.5
|
OAM
|
B:3SU306
|
4.4
|
35.9
|
0.5
|
CAI
|
B:3SU306
|
4.4
|
57.9
|
0.5
|
CAH
|
B:3SU306
|
4.4
|
26.6
|
0.5
|
CAE
|
B:3SU305
|
4.5
|
78.5
|
0.5
|
CAE
|
B:3SU305
|
4.6
|
35.0
|
0.5
|
CAJ
|
B:3SU306
|
4.7
|
64.3
|
0.5
|
CAH
|
B:3SU306
|
4.7
|
50.7
|
0.5
|
CAD
|
B:3SU306
|
4.7
|
46.3
|
0.5
|
CAE
|
B:3SU306
|
4.8
|
48.2
|
0.5
|
CAE
|
B:3SU306
|
4.8
|
25.3
|
0.5
|
SAP
|
B:3SU306
|
5.0
|
36.1
|
0.5
|
ND1
|
B:HIS131
|
5.0
|
24.7
|
1.0
|
CAD
|
B:3SU306
|
5.0
|
25.6
|
0.5
|
|
Bromine binding site 7 out
of 8 in 4wq3
Go back to
Bromine Binding Sites List in 4wq3
Bromine binding site 7 out
of 8 in the Human Calpain Pef(S) with (2Z,2Z')-2,2'-Disulfanediylbis(3-(6- Bromoindol-3-Yl)Acrylic Acid) Bound
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 7 of Human Calpain Pef(S) with (2Z,2Z')-2,2'-Disulfanediylbis(3-(6- Bromoindol-3-Yl)Acrylic Acid) Bound within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Br306
b:24.3
occ:0.50
|
BR
|
B:3SU306
|
0.0
|
24.3
|
0.5
|
BR
|
B:3SU306
|
0.5
|
43.6
|
0.5
|
CAB
|
B:3SU306
|
1.9
|
24.1
|
0.5
|
CAB
|
B:3SU306
|
2.4
|
43.9
|
0.5
|
CG1
|
B:VAL128
|
2.8
|
23.1
|
0.5
|
CAC
|
B:3SU306
|
2.9
|
25.2
|
0.5
|
CAG
|
B:3SU306
|
2.9
|
23.8
|
0.5
|
CAG
|
B:3SU306
|
3.2
|
44.4
|
0.5
|
CAC
|
B:3SU306
|
3.4
|
45.9
|
0.5
|
O
|
B:LEU124
|
3.5
|
16.5
|
1.0
|
CE2
|
B:PHE226
|
3.8
|
21.2
|
1.0
|
CD2
|
B:LEU124
|
3.9
|
19.8
|
1.0
|
CB
|
B:VAL128
|
4.0
|
20.9
|
0.5
|
N
|
B:VAL128
|
4.1
|
21.0
|
0.5
|
N
|
B:VAL128
|
4.1
|
20.3
|
0.5
|
CA
|
B:LEU124
|
4.1
|
16.7
|
1.0
|
CB
|
B:VAL128
|
4.1
|
22.6
|
0.5
|
CB
|
B:VAL127
|
4.2
|
22.1
|
1.0
|
CAF
|
B:3SU306
|
4.2
|
24.2
|
0.5
|
CE1
|
B:PHE139
|
4.2
|
17.7
|
1.0
|
C
|
B:LEU124
|
4.2
|
17.2
|
1.0
|
CAD
|
B:3SU306
|
4.2
|
25.6
|
0.5
|
CB
|
B:LEU124
|
4.2
|
15.1
|
1.0
|
CA
|
B:VAL128
|
4.3
|
22.3
|
0.5
|
CG1
|
B:VAL127
|
4.4
|
26.3
|
1.0
|
CZ
|
B:PHE226
|
4.4
|
20.3
|
1.0
|
CA
|
B:VAL128
|
4.4
|
23.7
|
0.5
|
CG2
|
B:VAL128
|
4.5
|
19.9
|
0.5
|
CZ
|
B:PHE139
|
4.5
|
18.4
|
1.0
|
CAF
|
B:3SU306
|
4.5
|
44.7
|
0.5
|
CG2
|
B:ILE171
|
4.7
|
17.5
|
1.0
|
CAE
|
B:3SU306
|
4.7
|
25.3
|
0.5
|
C
|
B:VAL127
|
4.7
|
20.8
|
1.0
|
CAD
|
B:3SU306
|
4.7
|
46.3
|
0.5
|
CG
|
B:LEU124
|
4.8
|
16.3
|
1.0
|
CD2
|
B:PHE226
|
4.8
|
19.0
|
1.0
|
CG2
|
B:VAL128
|
4.8
|
23.6
|
0.5
|
CA
|
B:VAL127
|
5.0
|
20.6
|
1.0
|
|
Bromine binding site 8 out
of 8 in 4wq3
Go back to
Bromine Binding Sites List in 4wq3
Bromine binding site 8 out
of 8 in the Human Calpain Pef(S) with (2Z,2Z')-2,2'-Disulfanediylbis(3-(6- Bromoindol-3-Yl)Acrylic Acid) Bound
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 8 of Human Calpain Pef(S) with (2Z,2Z')-2,2'-Disulfanediylbis(3-(6- Bromoindol-3-Yl)Acrylic Acid) Bound within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Br306
b:43.6
occ:0.50
|
BR
|
B:3SU306
|
0.0
|
43.6
|
0.5
|
BR
|
B:3SU306
|
0.5
|
24.3
|
0.5
|
CAB
|
B:3SU306
|
1.4
|
24.1
|
0.5
|
CAB
|
B:3SU306
|
1.9
|
43.9
|
0.5
|
CAC
|
B:3SU306
|
2.4
|
25.2
|
0.5
|
CAG
|
B:3SU306
|
2.5
|
23.8
|
0.5
|
CG1
|
B:VAL128
|
2.9
|
23.1
|
0.5
|
CAG
|
B:3SU306
|
2.9
|
44.4
|
0.5
|
CAC
|
B:3SU306
|
2.9
|
45.9
|
0.5
|
CE2
|
B:PHE226
|
3.7
|
21.2
|
1.0
|
CAD
|
B:3SU306
|
3.7
|
25.6
|
0.5
|
CAF
|
B:3SU306
|
3.7
|
24.2
|
0.5
|
O
|
B:LEU124
|
3.9
|
16.5
|
1.0
|
N
|
B:VAL128
|
4.1
|
21.0
|
0.5
|
CB
|
B:VAL127
|
4.1
|
22.1
|
1.0
|
CG1
|
B:VAL127
|
4.1
|
26.3
|
1.0
|
N
|
B:VAL128
|
4.1
|
20.3
|
0.5
|
CAF
|
B:3SU306
|
4.1
|
44.7
|
0.5
|
CB
|
B:VAL128
|
4.1
|
20.9
|
0.5
|
CB
|
B:VAL128
|
4.2
|
22.6
|
0.5
|
CAE
|
B:3SU306
|
4.2
|
25.3
|
0.5
|
CZ
|
B:PHE226
|
4.2
|
20.3
|
1.0
|
CAD
|
B:3SU306
|
4.2
|
46.3
|
0.5
|
CD2
|
B:LEU124
|
4.2
|
19.8
|
1.0
|
CA
|
B:VAL128
|
4.3
|
22.3
|
0.5
|
CA
|
B:VAL128
|
4.4
|
23.7
|
0.5
|
CG2
|
B:VAL128
|
4.5
|
19.9
|
0.5
|
CA
|
B:LEU124
|
4.6
|
16.7
|
1.0
|
CG2
|
B:ILE171
|
4.6
|
17.5
|
1.0
|
CE1
|
B:PHE139
|
4.6
|
17.7
|
1.0
|
C
|
B:LEU124
|
4.6
|
17.2
|
1.0
|
C
|
B:VAL127
|
4.7
|
20.8
|
1.0
|
CAE
|
B:3SU306
|
4.7
|
48.2
|
0.5
|
CB
|
B:LEU124
|
4.8
|
15.1
|
1.0
|
CD2
|
B:PHE226
|
4.8
|
19.0
|
1.0
|
CZ
|
B:PHE139
|
4.9
|
18.4
|
1.0
|
NAA
|
B:3SU306
|
5.0
|
24.8
|
0.5
|
CA
|
B:VAL127
|
5.0
|
20.6
|
1.0
|
|
Reference:
S.E.Adams,
E.J.Robinson,
D.J.Miller,
P.J.Rizkallah,
M.B.Hallett,
R.K.Allemann.
Conformationally Restricted Calpain Inhibitors. Chem Sci V. 6 6865 2015.
ISSN: ISSN 2041-6520
PubMed: 28757975
DOI: 10.1039/C5SC01158B
Page generated: Wed Jul 10 22:50:58 2024
|